Stream every public session from the 27th annual Global Conference right here on our website.

Watch Here
results for:

Content Type

Centers and Programs

Topics

Tags

Refine by Date

10
FasterCures Team landing page
FasterCures Team
Apr 20, 2021
Belle Tabas staff
Belle Tabas
Belle Tabas is a senior associate at FasterCures, a Center of the Milken Institute.
Apr 29, 2021
Yasmeen Long staff
Yasmeen Long
Yasmeen Long is a director at FasterCures, a Center of the Milken Institute. Her expertise lies w
ithin health equity, disparities, outcomes, policy, clinical research, patient engagement, and social determinants of health.
Apr 29, 2021
FasterCures Quarterly Update: July 2023 article
FasterCures Quarterly Update: July 2023
In This Issue: Convenings Recap Policy Updates FasterCures in the Media FasterCures in the Communit
y
Jul 13, 2023
Capital for Innovation landing page
Capital for Innovation
Core Activities The program pursues
Apr 20, 2021
Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief report
Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief
The Milken Institute Center for Public Health and FasterCures have identified three PAHPA 2023 poli
cy priorities that are core to improving and strengthening the nation’s biosecurity and preparedness infrastructure.
Jul 21, 2023
Collecting and Sharing Patient Data: Guiding Principles and Sustainability video
Collecting and Sharing Patient Data: Guiding Principles and Sustainability
Apr 19, 2021
Esther Krofah: Vaccines, Variants, and Lessons for the Next Pandemic video
Esther Krofah: Vaccines, Variants, and Lessons for the Next Pandemic
Esther Krofah, executive director of FasterCures, talks to COVID-19 Africa Watch about the public
health lessons learned so far from the COVID-19 pandemic.
Apr 9, 2021
Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870 article
Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
Submitted electronically Dr. Robert Califf Commissioner US Food and Drug Administration Silver Spri
ng, MD 20993 Dear Dr. Califf,
Jul 31, 2023
Discussion Draft of the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization article
Discussion Draft of the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization
Submitted electronically 
Jul 10, 2023